SK51296A3 - Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule Download PDF

Info

Publication number
SK51296A3
SK51296A3 SK512-96A SK51296A SK51296A3 SK 51296 A3 SK51296 A3 SK 51296A3 SK 51296 A SK51296 A SK 51296A SK 51296 A3 SK51296 A3 SK 51296A3
Authority
SK
Slovakia
Prior art keywords
red
light
chlorine
yellow
hydrogen
Prior art date
Application number
SK512-96A
Other languages
English (en)
Slovak (sk)
Inventor
Willard C Newlin Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SK51296A3 publication Critical patent/SK51296A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
SK512-96A 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule SK51296A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (fr) 1995-04-24 1995-04-24 Inhibition de la photodecomposition des 2-oxindoles-3-substitues

Publications (1)

Publication Number Publication Date
SK51296A3 true SK51296A3 (en) 1997-04-09

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
SK512-96A SK51296A3 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule

Country Status (30)

Country Link
EP (1) EP0827399A1 (fr)
JP (1) JPH10506635A (fr)
KR (1) KR100189585B1 (fr)
CN (1) CN1053667C (fr)
AP (1) AP607A (fr)
AR (1) AR002728A1 (fr)
AU (1) AU692378B2 (fr)
BG (1) BG100531A (fr)
BR (1) BR9602024A (fr)
CO (1) CO4700418A1 (fr)
FI (1) FI973988A0 (fr)
HR (1) HRP960194A2 (fr)
HU (1) HU216544B (fr)
IL (1) IL117969A0 (fr)
IS (1) IS4339A (fr)
MA (1) MA23848A1 (fr)
NO (1) NO961622L (fr)
NZ (1) NZ286432A (fr)
OA (1) OA10286A (fr)
PE (1) PE34397A1 (fr)
RO (1) RO113305B1 (fr)
RU (1) RU2109510C1 (fr)
SG (1) SG64924A1 (fr)
SI (1) SI9600133A (fr)
SK (1) SK51296A3 (fr)
TR (1) TR199600300A2 (fr)
UA (1) UA42739C2 (fr)
WO (1) WO1996033701A1 (fr)
YU (1) YU25096A (fr)
ZA (1) ZA963210B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3085172A1 (fr) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Stabilite oxydative amelioree d'emulsions huile dans eau a l'aide de stabilisants naturels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
MA23848A1 (fr) 1996-12-31
AP607A (en) 1997-08-27
SG64924A1 (en) 1999-05-25
AP9600787A0 (en) 1996-04-30
CN1053667C (zh) 2000-06-21
HUP9601057A2 (en) 1997-04-28
TR199600300A2 (tr) 1996-11-21
IL117969A0 (en) 1996-08-04
AU692378B2 (en) 1998-06-04
BR9602024A (pt) 1998-10-06
AR002728A1 (es) 1998-04-29
OA10286A (en) 1997-09-19
HU9601057D0 (en) 1996-06-28
IS4339A (is) 1996-10-25
CO4700418A1 (es) 1998-12-29
NO961622D0 (no) 1996-04-23
BG100531A (bg) 1997-06-30
AU5085196A (en) 1996-11-07
YU25096A (sh) 1998-08-14
WO1996033701A1 (fr) 1996-10-31
ZA963210B (en) 1997-10-23
RU2109510C1 (ru) 1998-04-27
CN1139110A (zh) 1997-01-01
HUP9601057A3 (en) 1997-05-28
SI9600133A (en) 1996-10-31
PE34397A1 (es) 1997-09-29
NO961622L (no) 1996-10-25
JPH10506635A (ja) 1998-06-30
FI973988A7 (fi) 1997-10-17
FI973988L (fi) 1997-10-17
KR960037656A (ko) 1996-11-19
UA42739C2 (uk) 2001-11-15
RO113305B1 (ro) 1998-06-30
NZ286432A (en) 1998-05-27
EP0827399A1 (fr) 1998-03-11
HU216544B (hu) 1999-07-28
FI973988A0 (fi) 1997-10-17
KR100189585B1 (ko) 1999-06-01
HRP960194A2 (en) 1998-02-28

Similar Documents

Publication Publication Date Title
US7932289B2 (en) Remedy for diabetes
RS66566B1 (sr) Farmaceutska kombinacija i kompozicija, i kombinovani preparat koji sadrži aktivator glukokinaze i biguanid hipoglikemijski lek kao i postupak njihove pripreme i upotrebe
CA2501587C (fr) Preparation solide ayant une phase contenant un melange homogene d'un sensibilisateur a l'insuline et d'un autre ingredient actif
AU2006278039A1 (en) Pharmaceutical composition comprising a DPP-lV inhibitor
MXPA06013711A (es) Formulacion de tableta revestida y metodo.
SK282183B6 (sk) Farmaceutický prostriedok
KR100952090B1 (ko) 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제
JP4739189B2 (ja) 固形製剤
NL8600302A (nl) Farmaceutische preparaten met analgetische werkzaamheid, alsmede de bereiding en toepassing ervan.
RU2109510C1 (ru) Способ ингибирования, таблетка и капсула
CA2216931A1 (fr) Inhibition de la photodecomposition des 2-oxindoles-3-substitues
US4333945A (en) Thiazoline and imidazoline derivatives useful as minor tranquilizers
US20250099451A1 (en) Pharmaceutical composition of a cyp11a1 inhibitor
KR20250159949A (ko) 안정성이 개선된 피타바스타틴을 포함하는 약학 조성물
JPS6323969B2 (fr)
AU2019449883A1 (en) Pharmaceutical composition containing alkynyl compound and preparation method and application thereof
MXPA97008155A (en) Inhibition of the photo-composition of 2-oxindoles 3-substitute
BG860Y1 (bg) Лекарствена форма на дипиридамол
TH11684B (th) สารผสมทางเภสัชกรรมที่เสถียรซึ่งประกอบด้วยสารยับ?ยั้ง HMG-CoA รีดักเตส
TH13801A (th) สารผสมทางเภสัชกรรมที่เสถียรซึ่งประกอบด้วยสารยับ?ยั้ง HMG-CoA รีดักเตส
HK1080385B (en) Solid preparation